OR WAIT null SECS
September 28, 2016
BASF’s new production facility in Shanghai will produce PVP K30 powder, a polymer used as a base for pharma excipients.
September 22, 2016
Dow and Colorcon extend and broaden the scope of the Controlled Release Alliance.
September 21, 2016
Clinical biotechnology company Moderna Therapeutics will build an integrated clinical manufacturing facility for mRNA production in Norwood, Massachusetts.
September 20, 2016
The certification follows a successful inspection by the MHRA, with no critical or major observations. The site is now ready to start production.
September 12, 2016
Saneca Pharma is making significant investment in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up.
September 02, 2016
Researchers at GlaxoSmithKline report a greener and lower-cost route to chiral fluorolactams that is suitable for scale up.
September 01, 2016
Sound process understanding and having effective controls in place are crucial in ensuring that consistent product quality is obtained during API manufacturing.
IPEC consultant Irwin Silverstein discusses third-party audits and regulatory compliance issues facing suppliers and their customers.
The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.
API and drug product manufacturer changes name to align with parent company.